Back in February, Lombard Medical received FDA approval to bring to U.S. market its Aorfix stent graft system for treating abdominal aortic aneurysms (AAAs). The Aorfix is the only approved stent graft for AAAs that is able to treat angulations of up to 90°.
Now the FDA has greenlighted Lombard’s next generation delivery system for the Aorfix graft, the Aorflex . The new delivery system promises to make delivery easier, and should cause less damage to vessel walls thanks to a new coating. It’s designed to withstand a good deal of pushing, twisting, and pulling for improved control during deployment.
- Smoother introduction of the delivery system into blood vessels through the use of a hydrophilic coating<
- Greater deployment control with exceptional one-to-one torque
- X-ray marker to give positional feedback to physicians
- Reduced deployment forces
Product page: Aorfix…
Press release: FDA Approves Next Generation Aorflex™ Delivery System